Autism Study
An Open-label (Part One) and a Randomized, Double-blind, Placebo-controlled (Part Two) Study of the Pharmcokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients with Autism
Protocol ID
09-10-144
Protocol Description
The purpose of this study is to evaluate the effect of an experimental drug to treat symptoms of autism in children. This study has two purposes. The first is to test how the study drug (memantine) is absorbed and eliminated by the body in 6-12 year old children with autism or autistic spectrum disorders, to help determine dosing in children. The second purpose is to test the tolerability and effectiveness of memantine compared to placebo.
Eligibility Criteria
Children with autism or autistic spectrum disorders
Primary Investigator(s)
- Joel Bregman, MD